C-Rad

Aging Population And Healthcare Digitization Will Expand Radiotherapy Demand

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

09 Feb 25

Updated

01 May 25

n/a

AnalystConsensusTarget's Fair Value

n/a

2.4%

-3.4%

2.4%

-3.4%

You can edit this narrative until May 12 5:58 AM. Then, changes will post as Updates.

Author's Valuation

SEK 3918.8% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates8

Shared on 01 May 25

Fair value Decreased 6.52%

Shared on 23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

Fair value Decreased 13%

AnalystConsensusTarget has decreased revenue growth from 13.4% to 11.9%.

Shared on 09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Increased 0.17%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 12 Mar 25

Fair value Increased 22%

AnalystConsensusTarget has decreased revenue growth from 15.8% to 13.3% and increased future PE multiple from 12.9x to 15.5x.

AnalystConsensusTarget Fair Value

SEK 39

18.8% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

10.68%

Medical Equipment revenue growth rate

8.17%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

5.75%

Calculation

SEK 148.83m

Earnings '28

10.17x

PE Ratio '28

SEK 1.51b

Market Cap '28

SEK 1.51b

Market Cap '28

33.58m

No. shares '28

SEK 45.08

Share Price '28

SEK 45.08 Share Price '28

Discounted to 2025 @ 5.56% p.a.

SEK 38.33

Fair Value '25